$599

Lifescan Wins Patent Dispute vs. Pharma Tech Solutions

The Federal Circuit Court of Appeals ruled to uphold a previous court ruling that Lifescan and J&J did not infringe upon Pharma Tech Solutions’s (Decision Diagnostics Corp parent company) blood glucose patents. Below, FENIX provides brief thoughts on the patent win for Lifescan.

This content is for members only.
Register
Already a member? Log in here